By Robert Chapman, M.D. and William Wood, R.PH.

This article was published in the inaugural issue of Oncology Payers.  Numerous examples are provided demonstrating how people across the nation who would otherwise be unable to pay for their oncology medications have been able to receive them through benefit of the 340B Discount Drug Program.  In many cases, the savings realized from participating in the 340B program have been critical to maintaining oncology programs and the hospitals where they are located open to help underserviced populations.

To view this article, use this link

To download a pdf of this article use this link.

Share this on Twitter: